Roles for CD40, B7 and major histocompatibility complex in induction of enhanced immunity by cryptococcal polysaccharide-pulsed antigen-presenting cells

Immunology

Volumn 108, Issue 2, 2003, Pages 158-166

  Blackstock, Rebecca ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY; POLYSACCHARIDE; VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; CYTOKINE PRODUCTION; CYTOKINE RESPONSIVE ELEMENT; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; IMMUNOMODULATION; INTERFERON PRODUCTION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR MODEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD40; ANTIGENS, CD80; ANTIGENS, FUNGAL; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FUNGAL VACCINES; HYPERSENSITIVITY, DELAYED; INTERFERON TYPE II; INTERLEUKIN-2; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; POLYSACCHARIDES; TH1 CELLS;

EID: 0037326475     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2003.01574.x     Document Type: Article

References (32)

1. Blackstock R, Buchanan KL, Adesina AM, Murphy JW. Differential regulation of immune responses by highly and weakly virulent Cryptococcus neoformans isolates. Infect Immun 1999; 67:3601-9.
2. Blackstock R, McCormack JM, Hall NK. Induction of a macrophage suppressive lymphokine by soluble cryptococcal antigens and its association with models of immunological tolerance. Infect Immun 1987; 55:233-9.
3. Blackstock R, Hernandez NC. Inhibition of phagocytosis in cryptococcosis: Phenotypic analysis of the suppressor cell. Cell Immunol 1988; 114:174-87.
4. Blackstock R, Hall NK, Hernandez NC. Characterization of a suppressor factor that regulates phagocytosis by macrophages in murine cryptococcosis. Infect Immun 1989; 57:1773-9.
5. Blackstock R, Zembala M, Asherson GL. Functional equivalence of cryptococcal and haptene-specific T-suppressor factor (TsF) 2. Monoclonal anti-cryptococcal TsF inhibits both phagocytosis by a subset of macrophages and transfer of contact sensitivity. Cell Immunol 1991; 136:448-61.
6. Murphy JW, Mosley RL, Cherniak R, Reyes G, Kozel TR, Reiss E. Serological, electrophoretic, and biological properties of Cryptococcus neoformans antigens. Infect Immun 1988; 56:424-31.
7. Murphy JW, Schafer F, Casadevall A, Adesina A. Antigen-induced protective and nonprotective cell-mediated immune components against Cryptococcus neformans. Infect Immun 1998; 66:2632-9.
8. Blackstock R, Casadevall A. Presentation of cryptococcal capsular polysaccharide (GXM) on activated antigen presenting cells inhibits the T-suppressor response and enhances delayed-type hypersensitivity and survival. Immunology 1997; 92:334-9.
9. Blackstock R, McElwee N, Neller E, Shaddix-White J. Regulation of cytokine expression in mice immunized with cryptococcal polysaccharide, a glucuronoxylomannan (GXM), associated with peritoneal antigen-presenting cells (APC): requirements for GXM, APC activation, and IL-12. Infect Immun 2000; 68:5146-53.
10. Blackstock R, Zembala M, Asherson GL. Functional equivalence of cryptococcal and haptene-specific T-suppressor factor (TsF) 1. Picryl and oxazolone-specific TsF, which inhibit transfer of contact sensitivity, also inhibit phagocytosis by a subset of macrophages. Cell Immunol 1991; 136:435-47.
11. Buchanan KL, Murphy JW. Characterization of cellular infiltrates and cytokine production during the expression phase of the anticryptococcal delayed-type hypersensitivity response. Infect Immun 1993; 61:2854-65.
12. Dubois M, Gilles KA, Hamilton JK, Rebers PA, Smith F. Colorimetric method for determination of sugars and related substances. Anal Chem 1956; 28:350-6.
13. Nowak TP, Barondes SH. Agglutinin from Limulus polyphemus. Purification with formalinized horse erythrocytes as the affinity adsorbent. Biochim Biophys Acta 1975; 393:115-23.
14. Blackstock R, Murphy JW. Secretion of the C3 component of complement by peritoneal cells cultured with encapsulated Cryptococcus neoformans. Infect Immun 1997; 65:4114-21.
15. Kalckar HM. Differential spectrophotometry of purine compounds by means of specific enzymes III. Studies of the enzymes of purine metabolism. J Biol Chem 1947; 167:461-75.
16. Chaussabel D, Jacobs F, De Jonge J, De Veerman M, Carlier Y, Thielemans K, Goldman M, Vray B. CD40 ligation prevents Trypanosoma cruzi infection through interleukin-12 upregulation. Infect Immun 1999; 67:1929-34.
17. Whitmire JD, Flavell RA, Grewal IS, Larsen CP, Pearson TC, Ahmed R. CD40-CD40 ligand costimulation is required for generating antiviral CD4 T cell responses but is dispensable for CD8 T cell responses. J Immunol 1999; 163:3194-201.
18. Marriott I, Thomas EK, Bost KL. CD40-CD40L interactions augment survival of normal mice, but not CD40 knockout mice, challenged orally with Salmonella dublin. Infect Immun 1999; 67:5253-7.
19. Linsley PS, Ledbetter JA. The role of the CD28 receptor during T-cell responses to antigen. Annu Rev Immunol 1993; 11:191-212.
20. Robinson BE, Hall NK, Bulmer GS, Blackstock R. Suppression of responses to cryptococcal antigen in cryptococcosis. Mycopathology 1982; 80:157-63.
21. Morgan MA, Blackstock R, Bulmer GS, Hall NK. Modification of macrophage phagocytosis in murine cryptococcosis. Infect Immun 1983; 40:493-500.
22. Johnson JG, Jenkins MK. Accessory cell-derived signals required for T-cell activation. Immunol Res 1993; 12:48-64.
23. Schweitzer AN, Borriello F, Wong RC, Abbas AK, Sharpe AH. Role of costimulators in T cell differentiation: studies using antigen-presenting cells lacking expression of CD80 or CD86. J Immunol 1997; 158:2713-22.
24. Bennett SRM, Carbone FR, Karamalis F, Flavell RA, Miller JFAP, Heath WR. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 1998; 393:478-80.
25. Grewal IS, Flavell RA. CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol 1998; 16:111-35.
26. Chapoval AI, Ni J, Lau JS et al. B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production. Nat Immunol 2001; 2:269-74.
27. Kanoh M, Uetani T, Sakan H, Maruyama S, Liu F, Sumita K, Asano Y. A two-step model of T cell subset commitment: antigen-independent commitment of T cells before encountering nominal antigen during pathogenic infections. Int Immunol 2002; 14:567-75.
28. Vandenberghe P, Verwilghen J, Van Vaeck F, Ceuppens JL. Ligation of the CD5 or CD28 molecules on resting human T cells induces expression of the early activation antigen CD69 by a calcium- and tyrosine kinase-dependent mechanism. Immunology 1993; 78:210-17.
29. Braley-Mullen H. Distinct populations of antigen-presenting cells are required for activation of suppressor and contrasuppressor T-cells by type-III pneumococcal polysaccharide. Cell Immunol 1990; 128:528-41.
30. Dong ZM, Murphy JW. Cryptococcal polysaccharides bind to CD18 on human neutrophils. Infect Immun 1997; 65:557-63.
31. Blackstock R. Cryptococcal capsular polysaccharide utilizes an antigen-presenting cell to induce a T-suppressor cell to secrete TsF. J Med Vet Mycol 1995; 34:19-30.
32. Murphy JW. Cell-Mediated Immunity. In: Howard DH, Miller JD, eds. The Mycota, Animal and Human Relationships, Vol VII. Heidelberg, Germany: Springer-Verlag, 1996:67-97.